Skip to main content
×
Home
    • Aa
    • Aa
  • The International Journal of Neuropsychopharmacology, Volume 7, Issue 4
  • December 2004, pp. 387-390

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

  • Todd D. Gould (a1), Haim Einat (a1), Ratan Bhat (a2) and Husseini K. Manji (a1)
  • DOI: http://dx.doi.org/10.1017/S1461145704004535
  • Published online: 01 November 2004
Abstract

The mechanism by which lithium exerts either its anti-manic or antidepressant effects remains to be fully elucidated. Although lithium inhibits the enzyme glycogen synthase kinase-3 (GSK-3) at concentrations that are relevant for treatment of bipolar disorder, it is unclear whether GSK-3-related mechanisms are responsible for its therapeutic effects in the treatment of this disease. We report that AR-A014418 (a selective GSK-3 inhibitor) induces behavioural changes that are consistent with the effects of antidepressant medications. Subacute intraperitoneal injections of AR-A014418 reduced immobility time in rats exposed to the forced swim test, a well-established model for antidepressant efficacy. In addition, the specificity of this effect is supported by our finding that AR-A014418 decreased spontaneous as well as amphetamine-induced activity. Taken together, these data support the hypothesis that lithium may exert its antidepressant effects through inhibition of GSK-3, and that novel small-molecule GSK-3 inhibitors may be useful for the treatment of bipolar disorder and depression.

Copyright
Corresponding author
Dr H. K. Manji, Laboratory of Molecular Pathophysiology, NIMH, NIH, 9000 Rockville Pike, Bldg 35, Room 16-912, Bethesda, MD 20892-3711, USA. Tel.: 301 496-9802 Fax: 301 480-0123 E-mail: manji@nih.gov
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: